WO2023166472A2 - Method of deploying an intraluminal device and intraluminal system - Google Patents

Method of deploying an intraluminal device and intraluminal system Download PDF

Info

Publication number
WO2023166472A2
WO2023166472A2 PCT/IB2023/051970 IB2023051970W WO2023166472A2 WO 2023166472 A2 WO2023166472 A2 WO 2023166472A2 IB 2023051970 W IB2023051970 W IB 2023051970W WO 2023166472 A2 WO2023166472 A2 WO 2023166472A2
Authority
WO
WIPO (PCT)
Prior art keywords
intraluminal device
stomach
filament
endoscope
intraluminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2023/051970
Other languages
French (fr)
Other versions
WO2023166472A3 (en
Inventor
Randal Baker
Frederick J. Walburn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BFKW LLC
Original Assignee
BFKW LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BFKW LLC filed Critical BFKW LLC
Priority to EP23763075.1A priority Critical patent/EP4486261A4/en
Priority to AU2023229218A priority patent/AU2023229218A1/en
Priority to CA3255550A priority patent/CA3255550A1/en
Priority to KR1020247033214A priority patent/KR20240161142A/en
Publication of WO2023166472A2 publication Critical patent/WO2023166472A2/en
Publication of WO2023166472A3 publication Critical patent/WO2023166472A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0076Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/003Implantable devices or invasive measures inflatable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0036Intragastrical devices
    • A61F5/004Intragastrical devices remotely adjustable
    • A61F5/0043Intragastrical devices remotely adjustable using injection ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0036Intragastrical devices
    • A61F5/004Intragastrical devices remotely adjustable
    • A61F5/0046Intragastrical devices remotely adjustable with wireless means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0076Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • A61F5/0079Pyloric or esophageal obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0089Instruments for placement or removal

Definitions

  • the present invention is directed to a method and system for deploying and anchoring an intraluminal device in a manner that applies stress to the cardiac portion of the stomach.
  • a system for deploying an intraluminal device to the cardiac region of the stomach includes having an intraluminal device with a wall defining a surface and an open portion of the wall that is alignable with the gastroesophageal (GE) junction.
  • the surface and the cardiac portion of the stomach are conformable with each other.
  • the intraluminal device is deployed trans-orally to the stomach with an endoscopic instrument.
  • the intraluminal device is retained in contact with the cardiac region of the stomach with the open portion generally aligned with the GE junction.
  • the intraluminal device is fastened from the abdominal cavity with at least one laparoscopic instrument.
  • the intraluminal device is visualized with an endoscope while it is being fastened in order to guide the laparoscopic instrument.
  • the intraluminal device may be deployed from an endoscopic instrument in the form of a deployment device in the stomach and the intraluminal device retained by positioning the release device within the open portion in the wall in order to generally align the opening with the GE junction.
  • the intraluminal device may further be retained by applying a proximal force on at least one retention filament connected with the wall and passing the retention filament through the esophagus.
  • the wall may have a mean radius measured from the open portion and wherein the fastening is within a half of the radius closest to said open portion. The fastening may be within a third of the radius closest to the open portion or within a quarter of the radius closest to the open portion.
  • the intraluminal device may be sutured with suture strands and the suture strands reinforced at the abdominal side of each suture strand.
  • the strands may be reinforced by providing radial restraint to the suture strands.
  • the radial restraint of the strands may include engaging adjacent suture strands with each other.
  • the reinforcing may include producing scar material in the stomach tissue contacted by the suture strand.
  • the scar material may be produced by positioning a biologically absorbable material, such as a pledget between the suture strand and the stomach tissue.
  • the suture stands may be made from a non-absorbable material. While the knot of the suture strand may be retracted to the stomach through the scar material to explant the intraluminal device after use, such knot material would not be retractable should non-absorbable reinforcing material had been used for reinforcement in the abdominal cavity.
  • the biologically absorbable material may include multiple layers, each having a different rate of absorption.
  • the layer with a highest rate of absorption may be positioned against the stomach wall.
  • the layer furthest from the stomach tissue may have an outer surface that is adapted to resist adhering to another surface.
  • the reinforcing member may include a structural component that resists warping.
  • the intraluminal device may be explanted by severing the suture strands in the stomach and pulling the knots of the severed suture strands through the stomach wall into the stomach.
  • the intraluminal device wall may include at least one structural member and the suturing includes straddling the at least one structural member with the suture strands.
  • the intraluminal device may be explanted by severing the suture strands at the at least one structural member and pulling the suture strands through the stomach wall into the stomach.
  • the intraluminal device may be explanted by severing the suture strands in the stomach and pulling the knots of the severed suture strands through the stomach wall into the stomach.
  • the intraluminal device may have a plurality of structural members and have a higher density of the structural members proximal the opening than distal the opening.
  • the stress applied to the cardiac portion of the stomach with the intraluminal device may be adjustable.
  • the applied stress may be adjustable with a controller affixed with the wall of the intraluminal device.
  • the applied stress may be adjustable by varying an amount of contact between the intraluminal device wall and the stomach wall.
  • the applied stress may be adjusted with at least one bladder that is connected with an external port.
  • the intraluminal device may be made at least in part from a bio-absorbable material.
  • the wall of the intraluminal device may include an involute collar around the opening.
  • the fastening may include having at least one magnet on either the wall of the intraluminal device engaging or in the abdominal cavity of the patient magnetically attracting a metallic member on the other of the wall or the abdominal cavity.
  • the fastening may be using various forms of fasteners inserted with the laparoscopic device.
  • the intraluminal device may be adapted for used as a bariatric device or to treat a metabolic disease.
  • the intraluminal device may be adapted for use to treat reflux disease or to treat hiatal hernia.
  • the intraluminal device may be explanted by severing the sutures in the stomach and retracting the severed suture strands into the stomach including pulling the knots through the stomach wall and removing the intraluminal device and suture strands through the esophagus.
  • An intraluminal system that is adapted to deploy an intraluminal device to the cardiac region of the stomach, according to an aspect of the invention, includes an intraluminal device having a wall defining a surface and an opening in said surface that is alignable with the gastroesophageal (GE) junction.
  • the surface and the cardiac portion of the stomach are conformable with each other.
  • the system includes an endoscopic deployment device that is adapted to deploying the intraluminal device trans-orally to the stomach and an endoscope and a laparoscopic instrument.
  • the endoscope is adapted to visualize the intraluminal device in the stomach while the intraluminal device is being fastened to the cardiac portion of the stomach.
  • the laparoscopic instrument is adapted to fasten the intraluminal device to the cardiac portion of the stomach from within the abdominal cavity while guided by the visualization of the intraluminal device by the endoscope.
  • the laparoscopic instrument is adapted to respond to the endoscope in order to adjust relative location between the laparoscopic instrument and the intraluminal device while the laparoscopic instrument is fastening the intraluminal device.
  • the deployment device may be a combination endoscope and deployment device defined by the intraluminal device positioned at an exterior surface of said endoscope.
  • the endoscope may include a shaft having a distal end portion that is adapted to be retroflexed and the intraluminal device is positioned proximal of the distal end portion.
  • the intraluminal device may have a self-expandable wall that is compressed to the endoscope shaft.
  • a compression device may be provided having a sleeve or a wrapped filament over the intraluminal device to keep the wall compressed to the endoscope.
  • a deploying filament may be provided to extend external the patient to release the compression device to allow the intraluminal device to selfexpand in the patient’s stomach.
  • One or more filament guides may be provided positioned on the endoscope shaft proximal the intraluminal device and adapted to guide movement of the deploying filament. Alternatively, the deploying filament may extend external the patient through a working channel of the endoscope.
  • a kit that is adapted for use with an endoscope having a shaft to convert the endoscope into a combination endoscope and intraluminal device release device includes a holder having an inner diameter that is larger than an external diameter of the endoscope shaft.
  • An intraluminal device having a self-expandable wall is positioned on the holder.
  • a compression device made up of a sleeve or a wrapped filament over the intraluminal device keeps the wall compressed to the holder.
  • a deploying filament extending external the patient, to release the compression device to allow the intraluminal device to self-expand.
  • One or more filament guides may be positioned on the holder and adapted to guide movement of the deploying filament when positioned on the endoscope shaft.
  • the holder may be adapted to receive the one or more filament guides and compression device after use of the combination endoscope and intraluminal device.
  • a method of converting an endoscope to a combination endoscope and intraluminal device release device using such a kit includes positioning the holder over the endoscope shaft and positioning the intraluminal device and compression device to the shaft by moving the intraluminal device and compression device from the holder to the endoscope shaft.
  • the endoscope may include a distal end portion that is adapted to be retroflexed and the method including positioning the intraluminal device and compression device proximal of the distal end portion.
  • One or more filament guides may be provided on the holder proximal to the intraluminal device and compression device and the method further including positioning the filament guide(s) on the endoscope shaft by moving filament guide(s) from the holder to the endoscope shaft before positioning the intraluminal device and compression device to the shaft.
  • the holder may be slid distally after moving each filament guide from the holder to the endoscope shaft and before moving the intraluminal device and compression device from the holder to the endoscope shaft.
  • the invention provides a minimally invasive technique for securely affixing an intraluminal device using mostly common surgical tools. This can be accomplished endoscopically and laparoscopically.
  • the intraluminal device can be easily explanted after use and, if the intraluminal device experiences distal migration, it will reside harmlessly in the stomach where it can be endoscopically retrieved or reaffixed.
  • the positioning of the intraluminal device against the cardiac portion of the stomach may simulate a sensation of fullness in the patient’s stomach in the absence of food or supplement fullness from the presence of food, using a variety of techniques. Pressure, or stress applied to the stomach wall may engage barro or stretch receptors in the stomach wall.
  • Peristalsis in the stomach wall may also create a sense of fullness by causing relative movement between the stomach wall and the wall of the intraluminal device thus activating the barro receptors. Activating of the barro receptors may cause neurohormonal change in the patient and trigger brain activity to affect satiety.
  • the intraluminal device performs its function without restricting any portion of the esophagus or encroaching upon the GE junction.
  • An intraluminal system that is adapted to deploy an intraluminal device to the cardiac region of the stomach, according to an aspect of the invention, includes an intraluminal device comprising a wall defining a surface and an open portion of the surface that is alignable with the gastroesophageal (GE) junction. The surface and the cardiac portion of the stomach are conformable with each other.
  • An endoscopic release device is adapted to deploying the intraluminal device trans-orally to the stomach.
  • An endoscope is adapted to visualize the intraluminal device in the stomach while the intraluminal device is being fastened to the cardiac portion of the stomach.
  • a laparoscopic instrument is adapted to fasten the intraluminal device to the cardiac portion of the stomach from within the abdominal cavity while guided based upon information gained from visualization of the intraluminal device during the fastening.
  • the deployment device is the endoscope with the intraluminal device positioned at an exterior surface of the endoscope.
  • Such combination of deployment device and visualization device eliminates one of the instruments deployed trans-orally in the patient. Since the endoscope does not need to fit through the center of a deployment device, a larger endoscope shaft diameter may be used while still fitting through the esophagus. Better visualization may be achieved with a larger diameter endoscope.
  • only a conversion kit as disclosed herein may be supplied and used to convert a conventional endoscope to a combination endoscope and deployment device. This reduces material usage and should lessen regulatory approval.
  • a disposable combination device may be provided that can be supplied in a single sterile package and disposed of after the procedure.
  • FIG. 1 is a perspective view of an intraluminal device deployed to a patient according to an embodiment of the invention
  • FIG. 2 is a sectional view of a release device with the intraluminal device mounted therein;
  • FIG. 3 is a medial elevational view of an intraluminal device
  • FIG. 4 medial elevational view illustrating positioning of the intraluminal device for attachment
  • FIG. 5 is a sectional view taken along the lines V-V in FIG. 1;
  • FIG. 5A is an enlarged plan view of an alternative embodiment of a reinforcing device
  • FIG. 6 is a sectional view taken along the lines VI- VI in FIG. 1 ;
  • FIG. 7 is a sectional view taken along the lines VII- VII in FIG. 5;
  • FIG. 8A-8E are perspective views of alternative embodiments of an intraluminal device
  • FIG. 9 is a median elevational view of an adjustable embodiment of an intraluminal device
  • FIG. 10 is a bottom plan view of another adjustable embodiment of an intraluminal device
  • FIG. 11 is a block diagram of a method of deploying an intraluminal device according to an aspect of the invention.
  • FIG. 12 is a perspective view of a kit that is adapted for use with an endoscope to convert the endoscope into a combination endoscope and intraluminal device deploying device;
  • FIG. 13 is perspective view of a combination endoscope and intraluminal device deploying device
  • FIG. 14 is an end elevational view of a filament guide
  • a method 9 is provided for deploying an intraluminal device 10 to the cardiac region of the stomach.
  • the intraluminal device 10 includes a wall 12 defining a surface 14 providing an open portion 16 that is alienable with the gastroesophageal (GE) junction of the patient. While open portion 16 is a generally central, through opening in wall 12 it could alternatively be a notch or other shape depending on the configuration of the intraluminal device. Wall 12 and the cardiac portion of the stomach are conformable to each other in order to stimulate baroreceptors in the wall of the cardiac portion of the stomach.
  • Wall 12 is constructed of a structural element 13 and a flexible membrane 15 between loops of the structural element.
  • Structural element 13 can be made from any suitable material that can provide rigidity but be flexible, such as a metal such as nitinol, or a polymeric material or carbon filament of the type known in the art. Structure element 13 may take various shapes such as seen in FIGS 6, 8A-8E and 10 in order to provide enough rigidity to wall 12 to apply suitable stress to the cardiac portion of the stomach without concentrating stress at particular locations. Yet, wall 12 is flexible enough to be able to be compressed to a deployment device 24.
  • Flexible membrane 15 can be made from a biocompatible material such as silicone, or the like, and of a suitable thickness to provide rigidity but be flexible.
  • Method 9 begins by providing laparoscopic access, such as by incision, between the stomach and the diaphragm and insufflating the abdomen at 17 (FIG. 11). Also, a visualization device, such as an endoscope 25 is trans-orally deployed to the stomach and a deployment device 24 is deployed to the stomach either over the endoscope or adjacent the endoscope (FIG. 4). As seen in FIG. 2, the intraluminal device 10 may be compressed between an inner tube 62 and an outer tube 64 of deployment device 24. Intraluminal device 10 is deployed in the stomach at 18 by proximal movement of outer tube 64 with respect to inner tube 62 which allows the intraluminal device to self-expand into its use configuration in the stomach.
  • a visualization device such as an endoscope 25 is trans-orally deployed to the stomach and a deployment device 24 is deployed to the stomach either over the endoscope or adjacent the endoscope (FIG. 4).
  • the intraluminal device 10 may be compressed between an inner tube 62 and an outer tube 64 of deployment device 24.
  • Endoscope 25 and deployment device 24 may each be a manual instruments that are manipulated by a surgeon or may be an end-of-arm tools that are manipulated by a surgical robot of the type that is commercially available from multiple sources.
  • the proximal force applied to the retention filaments brings intraluminal device 12 into contact with the cardiac portion of the stomach. Since the deployment device is positioned in the esophagus it generally aligns opening 16 with the GE junction so that ingested food passes through opening 16 not between wall 12 and the stomach wall. Such general alignment is also maintained with the deployment device during fastening of the intraluminal device to the stomach wall at 34.
  • Intraluminal device 10 is fastened at 34 from the abdominal cavity with at least one laparoscopic instrument 11 , such as a laparoscopic needle or other fastening device, while visualizing the intraluminal device with endoscope 25 from within the stomach while it is being fastened at 34.
  • the visualizing of the interaction between the laparoscopic instrument and the intraluminal device in the stomach guides further movement between the fastening device and the intraluminal device in order to properly carry out optimal fastening of the intraluminal device to the cardiac portion of the stomach.
  • one robot arm could operate laparoscopic instrument 11 in the form of an end of arm tool.
  • Another robot arm could operate endoscope 25 as an end of arm tool.
  • the fastening is with sutures in the form of individual strands 36 that are arranged a generally circular pattern around the esophagus, which is generally aligned with opening 16 by release device 24, as best seen in FIGS. 4 and 5.
  • Each suture strand is applied over a reinforcement, such as a pledge tt 44, between the suture strand and the outer stomach wall.
  • the suturing device causes the suture loop to penetrate the reinforcement 44, pass through the stomach wall as well as wall 12 of intraluminal device 10.
  • the suture loop then directed to straddle around a structural member 13 of wall 12 and then back through wall 12, the wall of the stomach and through the reinforcement 44 under guidance from visualization with endoscope 25.
  • the suture loop is then tied off thus forming a knot 38 using conventional techniques. All of this fastening is visualized from within the stomach using endoscope 25.
  • the laparoscopic fastening device may be a conventional instrument that is manipulated by a surgeon or may be an end-of-arm tool that is manipulated by a surgical robot of the type that is commercially available from multiple sources.
  • a reinforcement in the form of a radial restraint 40 is applied to the suture strands 36 in order avoid the suture material of the strands cutting through the stomach wall and releasing the fastening of the device.
  • Such radial constraint 40 could be applied by interweaving, or overlapping, the strands of adjacent loops 36, as best seen in FIGS 5 and 7 so that one strand applies radial restraint to the adjacent strand and vice versa.
  • radial restraint 40 could be applied by each reinforcement 44 being formed with an integral structural reinforcement in order to resist cutting of the reinforcement by the strands of suture loops 36.
  • the reinforcement may be provided by the production of scar material, such as collagen, in the stomach tissue contacted by a pledget 44.
  • scar material such as collagen
  • the reinforcement may be provided by the production of scar material, such as collagen, in the stomach tissue contacted by a pledget 44.
  • pledget 44 from a biologically absorbable, or resorbable, material of the type known in the art.
  • Such scar material is formed concurrently with and as a result of the biological absorption of the absorbable material making up pledget 44.
  • suture stands 36 are non-absorbable. This allows intraluminal device 10 to be deployed for an extended period of time without losing strength of fastening over time from an absorbable suture.
  • Pledget 44 may be made from multiple layers, each having a different rate of absorption.
  • the layer with the highest rate of absorption could be positioned against the stomach wall and other layer(s) further away.
  • the provision of an absorbable pledget thus provides two functions. It is absorbed by the patient so no laparoscopic access is needed to remove the pledget after use. Since the absorption of the reinforcement causes the formation of collagen or scar material, some reinforcement against penetration of the stomach tissue by the suture strands remains, even after the reinforcement is absorbed.
  • the entire non-absorbed suture can be retracted to the stomach because its knots can pull through the collage in in the stomach wall.
  • radial reinforcement 40 could include making the pledget 44 with an adherence surface feature that abuts the outer surface of the stomach that causes adherence between the restraint and the stomach. That adherence further strengthens the reinforcement in order to resist buckling.
  • the surface of the reinforcement facing away from the stomach may have a non-adherence surface to avoid adhesion with other surfaces in the abdomen.
  • a fold of stomach tissue may be made to wrap at least partially around pledget 44.
  • An additional pledget 44a may be positioned in a traversing fashion over pledget 44 as shown in FIG 5A.
  • Transverse pledget 44a may be affixed more loosely than pledget 44 in order to provide additional support yet allow lateral movement of pledget 44.
  • the placement of transverse pledget 44a provides the tissue fold to be sandwiched between two bio-absorbant pledgets 44, 44a. This further strengthens the tissue fold as additional collagen or scar material will form.
  • the severing of suture strands 36 may be conveniently performed where the suture material crosses the structural member or members 13 thus spacing the suture material from the wall of device 10.
  • the suture loops could be removed from the patient endoscopically or left in place loosely in the stomach to be passed on by peristalsis.
  • the intraluminal device is removed trans-orally.
  • the openings in the stomach wall left by the suture strands will heal.
  • Wall 12 may include an involute collar or ring around opening 16 to provide additional stiffness to wall 12 and may be large enough to capture suture loops 36. While the fastening of intraluminal device 10 is illustrated using a laparoscopic needles to apply sutures, other laparoscopic fastening techniques could be used such as applying mechanical fasteners from the abdomen.
  • Wall 12 of device 10 in the illustrated embodiment has a generally circular shaped circumference but may have any shape that is conformable with the cardiac portion of the stomach.
  • device 10 could have a flower-pedal shape, or the like.
  • Wall 12 has a mean radius 32 measured from the center of opening 16 to the outer edge.
  • Suture loops 36 are positioned within the half of radius 32 that is closest to opening 16. The suture loops may be within the third of the radius closest to said opening and may even be within the quarter of radius 32 closest to opening 16. This is advantageous because the portion of the stomach closest to the esophagus experiences the least amount of peristalsis because the portion of the stomach at the esophagus does not substantially move. So fastening wall 12 close to opening 16 minimizes movement of the sutures in response to peristalsis of the stomach.
  • an intraluminal device 110 is able to adjust stress applied to the cardiac portion of the stomach.
  • intraluminal device 110 includes a control 50 that has an internal module 52a implanted in the patient to adjust amount of stress applied by device 110.
  • Control 50 may further include an external module 52b that his external the patient and communicable with the internal module 52a such as by radio frequency wireless communication.
  • External module 52b may have a user interface (not shown) for operation by the user or a practitioner.
  • Device 110 may further have at least one bladder 54 between wall 112 and the cardiac portion of the stomach in fluid communication with at least one bladder 56 via a pump 46 that is controlled by internal control 52a. Stress can be adjusted by pumping fluid between bladder 54 and bladder 56.
  • bladder(s) 52a may be connected with a port at the patient’s skin surface for inflation or deflation via an external bladder or pump.
  • an intraluminal device 210 is able to adjust stress applied to the cardiac portion of the stomach.
  • intraluminal device 210 includes a control 150 that is interconnected to various portions of wall 112 by filaments 157 connected to the wall with fasteners 115.
  • control 150 may reduce or increase the surface area of surface 114 in contact with the cardiac portion of the stomach to adjust the applied stress. This may be facilitated by configuring wall 112 with leaves or flower pedals (not shown) that are each connected with one filament 157 to reduce the amount of force required to change the surface area in contact with the cardiac portion of the stomach.
  • controller 150 may have an external and internal control module as previously described. The inclusion of leaves may also make the intraluminal device more adaptable to various applications. For example, it may be applied to patients having an altered anatomy with the leaves useful for adapting to the anatomy of the patient.
  • the ability to adjust amount of stress applied by the intraluminal device allows the amount of satiety to be optimized to achieve desired weight loss. This may be accomplished by providing feedback to controller 150 of, for example, amount of weight loss. Controller 150 may then adjust mount of stress in order to optimize amount of satiety provided by the stress level.
  • FIGS. 8 A through 8E show various configurations of intraluminal devices 10A-10E with configurations of structural members 13A-13E.
  • Other configurations are possible.
  • segments of the structural members may be denser proximal the open portion of the intraluminal device than distal thereto. This increases the likelihood that suture strands will engage a structural member when the stands are placed closer to the opening.
  • intraluminal device 10 may have various uses.
  • the intraluminal device may be used as a bariatric device.
  • the intraluminal device may be used to treat a metabolic disease. Because the intraluminal device resists upward movement to the stomach wall it may be used to treat gastric reflux disease or hiatal hernia.
  • combination endoscope and deployment device 324 includes the intraluminal device 10 positioned at an exterior surface of shaft 325 of the endoscope.
  • a distal end portion 326 of endoscope shaft 325 includes a steerable portion 326 that can be retroflexed to visualize intraluminal device 10 during fastening to the cardiac portion of the stomach.
  • Intraluminal device wall 12 is a self-expandable wall that is compressed to endoscope shaft 325.
  • a compression device 238 keeps self-expandable wall 12 compressed to endoscope shaft 325.
  • Compression device 238 may be a sleeve over the intraluminal device, filament wrapped over intraluminal device wall 12, or the like.
  • a deploying filament 31 extends from compression device 328 through the esophagus to external the patient where it can be manipulated by the surgeon or surgical robot.
  • the deploying filament is adapted to release compression device 328 to allow intraluminal device 10 to self-expand in the patient’s stomach.
  • compression device 328 is a sleeve, it may be made with a series of openings so that a proximal force from the deploying filament will distort the sleeve to have an increase diameter to allow it to be slid off the intraluminal device.
  • compression device 328 is a filament wrapped over intraluminal device 10
  • the deploying filament may be an extension of the wrapped filament so that a proximal force from the deploying filament will remove the wrapped filament to allow the intraluminal device wall to self-expand.
  • Combination endoscope and deployment device 324 includes at least one filament guide
  • filament guide 336 positioned on endoscope shaft 333 positioned proximal to intraluminal device 10 and adapted to guide movement of deploying filament 31.
  • Filament guide 336 may also guide movement of retaining filaments 30.
  • filament guide 336 includes a circular band 337 that can grip shaft 325 to stay in a stationary position.
  • Filament guide 336 includes one or more guide channels 338 integral with band 337. Each guide channel 338 is for guiding movement of a retaining or a deploying filament 30, 31.
  • a plurality of filament guides 336 are spaced along shaft 325.
  • Kit 330 may be provide to convert a conventional endoscope to a combination endoscope and deployment device.
  • Kit 330 includes a holder 332 having an inner diameter that is larger than the outer diameter of the shaft of said endoscope.
  • holder 332 may have an inner diameter of 1.2 cm.
  • Intraluminal device 10 is compress on holder 332 by a compression device 328 made up of a sleeve or a wrapped filament over intraluminal device 10 and adapted to keep device wall 12 compressed to the holder with deploying filament 32.
  • Kit 330 may further include at least one filament guide 336 positioned on the holder and adapted to guide movement of the deploying filament 31.
  • Kit 330 may further includes one or more retention filaments 30 adapted to extend from the intraluminal device to external the patient, with the filament guide adapted to guide movement of the retention filaments.
  • Method 339 begins at 340 by positioning kit 330 over the shaft 325 of the endoscope with filament guides 336 proximal intraluminal device 10 and compression device 328.
  • a first filament guide is moved to the endoscope shaft at 342 by sliding the guide off of the holder and contracting to the endoscope shaft 325.
  • the holder is then slid distally along the endoscope at 342. If another filament guide remains on the holder (344), steps 342 and 343 are repeated.
  • the intraluminal device and compression device are moved from the holder to the endoscope shaft at 345 by sliding both off the holder where they will compress further to grip the shaft.
  • the holder is then slid off the endoscope shaft at 346 to complete the method.
  • the filament guides and compression device may be removed from the endoscope shaft after the intraluminal device is affixed to the patient by reversing method 339.
  • holder 332 could be retained to the endoscope’s shaft during use so that it is available for use to remove kit 330 after the intraluminal device is deployed. This may be accomplished by having friction members, such as wide bands, extending from one or both end of holder 332 to grip the shaft, other variations will be apparent to the skilled artisan.
  • Robotic system 400 has an esophageal robotic portion end-of-arm tool 404 that both deploys the intraluminal device in the stomach and visualizes the intraluminal device while it is being fastened.
  • Robotic system 400 further has an abdominal robotic portion 406 that carries out fastening of the intraluminal device to the cardiac portion of the stomach from the abdominal cavity.
  • a robotic control 402 adjusts the relative position between tools 404 and 406 to ensure that the intraluminal device is properly engaged by the fasteners and that the anatomy of the patient is not compromised by the deployment process.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nursing (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Surgical Instruments (AREA)
  • Endoscopes (AREA)

Abstract

A method of deploying an intraluminal device to the cardiac region of the stomach and a system used to deploy an intraluminal device to the cardiac region of the stomach, wherein the intraluminal device has a wall defining a surface and an open portion of the surface that is adapted to be aligned with the gastroesophageal (GE) junction. The surface and the cardiac portion of the stomach are conformable with each other. The method includes deploying the intraluminal device trans-orally to the stomach with an endoscopic deployment device and retaining the device against the cardiac region of the stomach with the open portion generally aligned with the GE junction. The intraluminal device is fastened to the stomach from the abdominal cavity with at least one laparoscopic instrument while concurrently visualizing the device with an endoscope in the stomach while it is being fastened. The laparoscopic instrument is adapted to respond to the endoscope in order to adjust location between the laparoscopic instrument and intraluminal device while the laparoscopic instrument is fastening the intraluminal device.

Description

METHOD OF DEPLOYING AN INTRALUMINAL DEVICE AND INTRALUMINAL
SYSTEM
BACKGROUND OF THE INVENTION
[0001] The present invention is directed to a method and system for deploying and anchoring an intraluminal device in a manner that applies stress to the cardiac portion of the stomach.
SUMMARY OF THE INVENTION
[0002] A system for deploying an intraluminal device to the cardiac region of the stomach, according to an aspect of the invention, includes having an intraluminal device with a wall defining a surface and an open portion of the wall that is alignable with the gastroesophageal (GE) junction. The surface and the cardiac portion of the stomach are conformable with each other. The intraluminal device is deployed trans-orally to the stomach with an endoscopic instrument. The intraluminal device is retained in contact with the cardiac region of the stomach with the open portion generally aligned with the GE junction. The intraluminal device is fastened from the abdominal cavity with at least one laparoscopic instrument. The intraluminal device is visualized with an endoscope while it is being fastened in order to guide the laparoscopic instrument.
[0003] The intraluminal device may be deployed from an endoscopic instrument in the form of a deployment device in the stomach and the intraluminal device retained by positioning the release device within the open portion in the wall in order to generally align the opening with the GE junction. The intraluminal device may further be retained by applying a proximal force on at least one retention filament connected with the wall and passing the retention filament through the esophagus. The wall may have a mean radius measured from the open portion and wherein the fastening is within a half of the radius closest to said open portion. The fastening may be within a third of the radius closest to the open portion or within a quarter of the radius closest to the open portion.
[0004] The intraluminal device may be sutured with suture strands and the suture strands reinforced at the abdominal side of each suture strand. The strands may be reinforced by providing radial restraint to the suture strands. The radial restraint of the strands may include engaging adjacent suture strands with each other. The reinforcing may include producing scar material in the stomach tissue contacted by the suture strand. The scar material may be produced by positioning a biologically absorbable material, such as a pledget between the suture strand and the stomach tissue. The suture stands may be made from a non-absorbable material. While the knot of the suture strand may be retracted to the stomach through the scar material to explant the intraluminal device after use, such knot material would not be retractable should non-absorbable reinforcing material had been used for reinforcement in the abdominal cavity.
The biologically absorbable material may include multiple layers, each having a different rate of absorption. The layer with a highest rate of absorption may be positioned against the stomach wall. The layer furthest from the stomach tissue may have an outer surface that is adapted to resist adhering to another surface. Alternatively, or in addition, the reinforcing member may include a structural component that resists warping. The intraluminal device may be explanted by severing the suture strands in the stomach and pulling the knots of the severed suture strands through the stomach wall into the stomach.
[0005] The intraluminal device wall may include at least one structural member and the suturing includes straddling the at least one structural member with the suture strands. The intraluminal device may be explanted by severing the suture strands at the at least one structural member and pulling the suture strands through the stomach wall into the stomach. The intraluminal device may be explanted by severing the suture strands in the stomach and pulling the knots of the severed suture strands through the stomach wall into the stomach. The intraluminal device may have a plurality of structural members and have a higher density of the structural members proximal the opening than distal the opening.
[0006] The stress applied to the cardiac portion of the stomach with the intraluminal device may be adjustable. The applied stress may be adjustable with a controller affixed with the wall of the intraluminal device. The applied stress may be adjustable by varying an amount of contact between the intraluminal device wall and the stomach wall. The applied stress may be adjusted with at least one bladder that is connected with an external port.
[0007] The intraluminal device may be made at least in part from a bio-absorbable material.
The wall of the intraluminal device may include an involute collar around the opening. The fastening may include having at least one magnet on either the wall of the intraluminal device engaging or in the abdominal cavity of the patient magnetically attracting a metallic member on the other of the wall or the abdominal cavity. The fastening may be using various forms of fasteners inserted with the laparoscopic device.
[0008] The intraluminal device may be adapted for used as a bariatric device or to treat a metabolic disease. The intraluminal device may be adapted for use to treat reflux disease or to treat hiatal hernia. The intraluminal device may be explanted by severing the sutures in the stomach and retracting the severed suture strands into the stomach including pulling the knots through the stomach wall and removing the intraluminal device and suture strands through the esophagus.
An intraluminal system that is adapted to deploy an intraluminal device to the cardiac region of the stomach, according to an aspect of the invention, includes an intraluminal device having a wall defining a surface and an opening in said surface that is alignable with the gastroesophageal (GE) junction. The surface and the cardiac portion of the stomach are conformable with each other. The system includes an endoscopic deployment device that is adapted to deploying the intraluminal device trans-orally to the stomach and an endoscope and a laparoscopic instrument. The endoscope is adapted to visualize the intraluminal device in the stomach while the intraluminal device is being fastened to the cardiac portion of the stomach. The laparoscopic instrument is adapted to fasten the intraluminal device to the cardiac portion of the stomach from within the abdominal cavity while guided by the visualization of the intraluminal device by the endoscope. The laparoscopic instrument is adapted to respond to the endoscope in order to adjust relative location between the laparoscopic instrument and the intraluminal device while the laparoscopic instrument is fastening the intraluminal device.
The deployment device may be a combination endoscope and deployment device defined by the intraluminal device positioned at an exterior surface of said endoscope. The endoscope may include a shaft having a distal end portion that is adapted to be retroflexed and the intraluminal device is positioned proximal of the distal end portion. The intraluminal device may have a self-expandable wall that is compressed to the endoscope shaft. A compression device may be provided having a sleeve or a wrapped filament over the intraluminal device to keep the wall compressed to the endoscope. A deploying filament may be provided to extend external the patient to release the compression device to allow the intraluminal device to selfexpand in the patient’s stomach. One or more filament guides may be provided positioned on the endoscope shaft proximal the intraluminal device and adapted to guide movement of the deploying filament. Alternatively, the deploying filament may extend external the patient through a working channel of the endoscope.
A kit that is adapted for use with an endoscope having a shaft to convert the endoscope into a combination endoscope and intraluminal device release device, according to an aspect of the invention, includes a holder having an inner diameter that is larger than an external diameter of the endoscope shaft. An intraluminal device having a self-expandable wall is positioned on the holder. A compression device made up of a sleeve or a wrapped filament over the intraluminal device keeps the wall compressed to the holder. A deploying filament extending external the patient, to release the compression device to allow the intraluminal device to self-expand.
One or more filament guides may be positioned on the holder and adapted to guide movement of the deploying filament when positioned on the endoscope shaft.
The holder may be adapted to receive the one or more filament guides and compression device after use of the combination endoscope and intraluminal device.
[0009] A method of converting an endoscope to a combination endoscope and intraluminal device release device using such a kit, according to an aspect of the invention, includes positioning the holder over the endoscope shaft and positioning the intraluminal device and compression device to the shaft by moving the intraluminal device and compression device from the holder to the endoscope shaft.
[0010] The endoscope may include a distal end portion that is adapted to be retroflexed and the method including positioning the intraluminal device and compression device proximal of the distal end portion. One or more filament guides may be provided on the holder proximal to the intraluminal device and compression device and the method further including positioning the filament guide(s) on the endoscope shaft by moving filament guide(s) from the holder to the endoscope shaft before positioning the intraluminal device and compression device to the shaft. The holder may be slid distally after moving each filament guide from the holder to the endoscope shaft and before moving the intraluminal device and compression device from the holder to the endoscope shaft. [0011] The invention provides a minimally invasive technique for securely affixing an intraluminal device using mostly common surgical tools. This can be accomplished endoscopically and laparoscopically. The intraluminal device can be easily explanted after use and, if the intraluminal device experiences distal migration, it will reside harmlessly in the stomach where it can be endoscopically retrieved or reaffixed. The positioning of the intraluminal device against the cardiac portion of the stomach may simulate a sensation of fullness in the patient’s stomach in the absence of food or supplement fullness from the presence of food, using a variety of techniques. Pressure, or stress applied to the stomach wall may engage barro or stretch receptors in the stomach wall. Peristalsis in the stomach wall may also create a sense of fullness by causing relative movement between the stomach wall and the wall of the intraluminal device thus activating the barro receptors. Activating of the barro receptors may cause neurohormonal change in the patient and trigger brain activity to affect satiety. The intraluminal device performs its function without restricting any portion of the esophagus or encroaching upon the GE junction.
[0012] An intraluminal system that is adapted to deploy an intraluminal device to the cardiac region of the stomach, according to an aspect of the invention, includes an intraluminal device comprising a wall defining a surface and an open portion of the surface that is alignable with the gastroesophageal (GE) junction. The surface and the cardiac portion of the stomach are conformable with each other. An endoscopic release device is adapted to deploying the intraluminal device trans-orally to the stomach. An endoscope is adapted to visualize the intraluminal device in the stomach while the intraluminal device is being fastened to the cardiac portion of the stomach. A laparoscopic instrument is adapted to fasten the intraluminal device to the cardiac portion of the stomach from within the abdominal cavity while guided based upon information gained from visualization of the intraluminal device during the fastening.
[0013] The deployment device, according to an aspect of the invention, is the endoscope with the intraluminal device positioned at an exterior surface of the endoscope. Such combination of deployment device and visualization device eliminates one of the instruments deployed trans-orally in the patient. Since the endoscope does not need to fit through the center of a deployment device, a larger endoscope shaft diameter may be used while still fitting through the esophagus. Better visualization may be achieved with a larger diameter endoscope. Also, only a conversion kit as disclosed herein, may be supplied and used to convert a conventional endoscope to a combination endoscope and deployment device. This reduces material usage and should lessen regulatory approval. Also, a disposable combination device may be provided that can be supplied in a single sterile package and disposed of after the procedure.
[0014] These and other objects, advantages, purposes and features of this invention will become apparent upon review of the following specification in conjunction with the drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0015] FIG. 1 is a perspective view of an intraluminal device deployed to a patient according to an embodiment of the invention;
[0016] FIG. 2 is a sectional view of a release device with the intraluminal device mounted therein;
[0017] FIG. 3 is a medial elevational view of an intraluminal device;
[0018] FIG. 4 medial elevational view illustrating positioning of the intraluminal device for attachment;
[0019] FIG. 5 is a sectional view taken along the lines V-V in FIG. 1;
[0020] FIG. 5A is an enlarged plan view of an alternative embodiment of a reinforcing device;
[0021] FIG. 6 is a sectional view taken along the lines VI- VI in FIG. 1 ;
[0022] FIG. 7 is a sectional view taken along the lines VII- VII in FIG. 5;
[0023] FIG. 8A-8E are perspective views of alternative embodiments of an intraluminal device;
[0024] FIG. 9 is a median elevational view of an adjustable embodiment of an intraluminal device;
[0025] FIG. 10 is a bottom plan view of another adjustable embodiment of an intraluminal device;
[0026] FIG. 11 is a block diagram of a method of deploying an intraluminal device according to an aspect of the invention;
[0027] FIG. 12 is a perspective view of a kit that is adapted for use with an endoscope to convert the endoscope into a combination endoscope and intraluminal device deploying device;
[0028] FIG. 13 is perspective view of a combination endoscope and intraluminal device deploying device;
[0029] FIG. 14 is an end elevational view of a filament guide;
[0030] FIG. 15 is a block diagram of a method of converting an endoscope into a combination endoscope and intraluminal device deploying device; and [0031] FIG. 16 is a block diagram of an intraluminal system that is adapted to deploy an intraluminal device to the cardiac region of the stomach.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0032] The present invention will now be described with reference to the accompanying figures, wherein the numbered elements in the following written description correspond to like- numbered elements in the figures. A method 9 is provided for deploying an intraluminal device 10 to the cardiac region of the stomach. The intraluminal device 10 includes a wall 12 defining a surface 14 providing an open portion 16 that is alienable with the gastroesophageal (GE) junction of the patient. While open portion 16 is a generally central, through opening in wall 12 it could alternatively be a notch or other shape depending on the configuration of the intraluminal device. Wall 12 and the cardiac portion of the stomach are conformable to each other in order to stimulate baroreceptors in the wall of the cardiac portion of the stomach. This may be accomplished by the fastening of wall 12 to the stomach wall bringing the device wall and the stomach wall into physical contact in order to apply stress to the wall of the stomach. Alternatively, device wall 12 and the stomach wall may be more loosely joined so that the peristalsis of the stomach will bring the stomach wall into engagement will the device wall to stimulate baroreceptors. Detail operation of intraluminal device 10 is described in Patent Number US 7,846,174 and Patent Application Publication US 2016/0151233, the disclosures of which are hereby incorporated herein by reference in their entirely.
[0033] Wall 12 is constructed of a structural element 13 and a flexible membrane 15 between loops of the structural element. Structural element 13 can be made from any suitable material that can provide rigidity but be flexible, such as a metal such as nitinol, or a polymeric material or carbon filament of the type known in the art. Structure element 13 may take various shapes such as seen in FIGS 6, 8A-8E and 10 in order to provide enough rigidity to wall 12 to apply suitable stress to the cardiac portion of the stomach without concentrating stress at particular locations. Yet, wall 12 is flexible enough to be able to be compressed to a deployment device 24. Flexible membrane 15 can be made from a biocompatible material such as silicone, or the like, and of a suitable thickness to provide rigidity but be flexible.
[0034] Method 9 begins by providing laparoscopic access, such as by incision, between the stomach and the diaphragm and insufflating the abdomen at 17 (FIG. 11). Also, a visualization device, such as an endoscope 25 is trans-orally deployed to the stomach and a deployment device 24 is deployed to the stomach either over the endoscope or adjacent the endoscope (FIG. 4). As seen in FIG. 2, the intraluminal device 10 may be compressed between an inner tube 62 and an outer tube 64 of deployment device 24. Intraluminal device 10 is deployed in the stomach at 18 by proximal movement of outer tube 64 with respect to inner tube 62 which allows the intraluminal device to self-expand into its use configuration in the stomach. The stomach is insufflated using the endoscope and the endoscope is retroflexed as seen in FIG. 4 in order to visualize the intraluminal device during affixation. Endoscope 25 and deployment device 24 may each be a manual instruments that are manipulated by a surgeon or may be an end-of-arm tools that are manipulated by a surgical robot of the type that is commercially available from multiple sources.
[0035] Deployment device 24, whose outer diameter is less than the diameter of opening, or open portion 16, is then positioned at 20 with its outer tube 64 within opening 16 while a proximal force is placed on retention filaments 30 which are looped around a proximal portion of the intraluminal device and extend out of the patient’s mouth. The proximal force applied to the retention filaments brings intraluminal device 12 into contact with the cardiac portion of the stomach. Since the deployment device is positioned in the esophagus it generally aligns opening 16 with the GE junction so that ingested food passes through opening 16 not between wall 12 and the stomach wall. Such general alignment is also maintained with the deployment device during fastening of the intraluminal device to the stomach wall at 34.
[0036] Intraluminal device 10 is fastened at 34 from the abdominal cavity with at least one laparoscopic instrument 11 , such as a laparoscopic needle or other fastening device, while visualizing the intraluminal device with endoscope 25 from within the stomach while it is being fastened at 34. The visualizing of the interaction between the laparoscopic instrument and the intraluminal device in the stomach guides further movement between the fastening device and the intraluminal device in order to properly carry out optimal fastening of the intraluminal device to the cardiac portion of the stomach. For example, if used with a surgical robot, one robot arm could operate laparoscopic instrument 11 in the form of an end of arm tool. Another robot arm could operate endoscope 25 as an end of arm tool. Images captured by the endoscope in the stomach could then be used by a common robot controller to guide movement of laparoscopic instrument 11 in order to endure proper engagement between attachment fasteners and the intraluminal device. [0037] In the illustrated embodiment, the fastening is with sutures in the form of individual strands 36 that are arranged a generally circular pattern around the esophagus, which is generally aligned with opening 16 by release device 24, as best seen in FIGS. 4 and 5. Each suture strand is applied over a reinforcement, such as a pledge tt 44, between the suture strand and the outer stomach wall. The suturing device causes the suture loop to penetrate the reinforcement 44, pass through the stomach wall as well as wall 12 of intraluminal device 10. The suture loop then directed to straddle around a structural member 13 of wall 12 and then back through wall 12, the wall of the stomach and through the reinforcement 44 under guidance from visualization with endoscope 25. The suture loop is then tied off thus forming a knot 38 using conventional techniques. All of this fastening is visualized from within the stomach using endoscope 25. The laparoscopic fastening device may be a conventional instrument that is manipulated by a surgeon or may be an end-of-arm tool that is manipulated by a surgical robot of the type that is commercially available from multiple sources.
[0038] A reinforcement in the form of a radial restraint 40 is applied to the suture strands 36 in order avoid the suture material of the strands cutting through the stomach wall and releasing the fastening of the device. Such radial constraint 40 could be applied by interweaving, or overlapping, the strands of adjacent loops 36, as best seen in FIGS 5 and 7 so that one strand applies radial restraint to the adjacent strand and vice versa. Alternatively, radial restraint 40 could be applied by each reinforcement 44 being formed with an integral structural reinforcement in order to resist cutting of the reinforcement by the strands of suture loops 36.
[0039] Alternatively, or additionally, the reinforcement may be provided by the production of scar material, such as collagen, in the stomach tissue contacted by a pledget 44. This occurs in the illustrated embodiment, by making pledget 44 from a biologically absorbable, or resorbable, material of the type known in the art. Such scar material is formed concurrently with and as a result of the biological absorption of the absorbable material making up pledget 44. In the illustrated embodiment, suture stands 36 are non-absorbable. This allows intraluminal device 10 to be deployed for an extended period of time without losing strength of fastening over time from an absorbable suture. Pledget 44 may be made from multiple layers, each having a different rate of absorption. The layer with the highest rate of absorption could be positioned against the stomach wall and other layer(s) further away. The provision of an absorbable pledget thus provides two functions. It is absorbed by the patient so no laparoscopic access is needed to remove the pledget after use. Since the absorption of the reinforcement causes the formation of collagen or scar material, some reinforcement against penetration of the stomach tissue by the suture strands remains, even after the reinforcement is absorbed.
However, after being severed in the stomach, the entire non-absorbed suture can be retracted to the stomach because its knots can pull through the collage in in the stomach wall.
[0040] Explantation of intraluminal device at 68, such as after weeks or months of use, or longer, as will be described in more detail below. The suture strands 36 are severed in the stomach such as with an endoscopically deployed scissors and knots 38 pulled through the stomach wall into the stomach to allow the suture strands to be removed endoscopically or pass through the intestines. While the knot would resist being pulled through a reinforcement made from a rigid material, the absorbable reinforcement should be at least mostly absorbed by the time of explantation, and replaced with scar tissue. Knots 38 can be pulled through such scar tissue yet the scar tissue is sufficiently rigid to provide reinforcement to the suture strand to resist their cutting of stomach tissue. Since the pledget 44 will have been all or mostly absorbed by the time of explantation of device 10, the device and all other components such as suture strands, can be removed endoscopically from the stomach. Therefore, no portion of the implanted device will remain behind in the patient after explanation and the explantation does not require any invasive procedure such as laparoscopic incisions. Alternatively, or additionally, radial reinforcement 40 could include making the pledget 44 with an adherence surface feature that abuts the outer surface of the stomach that causes adherence between the restraint and the stomach. That adherence further strengthens the reinforcement in order to resist buckling. The surface of the reinforcement facing away from the stomach may have a non-adherence surface to avoid adhesion with other surfaces in the abdomen.
[0041] While intraluminal device 10 is being fastening such as by suturing, a fold of stomach tissue may be made to wrap at least partially around pledget 44. An additional pledget 44a may be positioned in a traversing fashion over pledget 44 as shown in FIG 5A. Transverse pledget 44a may be affixed more loosely than pledget 44 in order to provide additional support yet allow lateral movement of pledget 44. With a tissue fold at least partially wrapped around pledget 44, the placement of transverse pledget 44a provides the tissue fold to be sandwiched between two bio-absorbant pledgets 44, 44a. This further strengthens the tissue fold as additional collagen or scar material will form. [0042] The severing of suture strands 36, such as with an endoscopic scissors or the like, may be conveniently performed where the suture material crosses the structural member or members 13 thus spacing the suture material from the wall of device 10. The suture loops could be removed from the patient endoscopically or left in place loosely in the stomach to be passed on by peristalsis. The intraluminal device is removed trans-orally. The openings in the stomach wall left by the suture strands will heal. Wall 12 may include an involute collar or ring around opening 16 to provide additional stiffness to wall 12 and may be large enough to capture suture loops 36. While the fastening of intraluminal device 10 is illustrated using a laparoscopic needles to apply sutures, other laparoscopic fastening techniques could be used such as applying mechanical fasteners from the abdomen.
[0043] Wall 12 of device 10 in the illustrated embodiment has a generally circular shaped circumference but may have any shape that is conformable with the cardiac portion of the stomach. For example, although as shown as circular or elliptical, device 10 could have a flower-pedal shape, or the like. Wall 12 has a mean radius 32 measured from the center of opening 16 to the outer edge. Suture loops 36 are positioned within the half of radius 32 that is closest to opening 16. The suture loops may be within the third of the radius closest to said opening and may even be within the quarter of radius 32 closest to opening 16. This is advantageous because the portion of the stomach closest to the esophagus experiences the least amount of peristalsis because the portion of the stomach at the esophagus does not substantially move. So fastening wall 12 close to opening 16 minimizes movement of the sutures in response to peristalsis of the stomach.
[0044] In an alternative embodiment, an intraluminal device 110 is able to adjust stress applied to the cardiac portion of the stomach. Referring to FIG. 9, intraluminal device 110 includes a control 50 that has an internal module 52a implanted in the patient to adjust amount of stress applied by device 110. Control 50 may further include an external module 52b that his external the patient and communicable with the internal module 52a such as by radio frequency wireless communication. External module 52b may have a user interface (not shown) for operation by the user or a practitioner. Device 110 may further have at least one bladder 54 between wall 112 and the cardiac portion of the stomach in fluid communication with at least one bladder 56 via a pump 46 that is controlled by internal control 52a. Stress can be adjusted by pumping fluid between bladder 54 and bladder 56. Instead of an electronic control, bladder(s) 52a may be connected with a port at the patient’s skin surface for inflation or deflation via an external bladder or pump.
[0045] In another alternative embodiment, an intraluminal device 210 is able to adjust stress applied to the cardiac portion of the stomach. Referring to FIG. 10, intraluminal device 210 includes a control 150 that is interconnected to various portions of wall 112 by filaments 157 connected to the wall with fasteners 115. By adjusting the length of filaments 157, control 150 may reduce or increase the surface area of surface 114 in contact with the cardiac portion of the stomach to adjust the applied stress. This may be facilitated by configuring wall 112 with leaves or flower pedals (not shown) that are each connected with one filament 157 to reduce the amount of force required to change the surface area in contact with the cardiac portion of the stomach. While not shown in FIG. 10, controller 150 may have an external and internal control module as previously described. The inclusion of leaves may also make the intraluminal device more adaptable to various applications. For example, it may be applied to patients having an altered anatomy with the leaves useful for adapting to the anatomy of the patient.
[0046] The ability to adjust amount of stress applied by the intraluminal device allows the amount of satiety to be optimized to achieve desired weight loss. This may be accomplished by providing feedback to controller 150 of, for example, amount of weight loss. Controller 150 may then adjust mount of stress in order to optimize amount of satiety provided by the stress level.
[0047] FIGS. 8 A through 8E show various configurations of intraluminal devices 10A-10E with configurations of structural members 13A-13E. Other configurations are possible. For example, segments of the structural members may be denser proximal the open portion of the intraluminal device than distal thereto. This increases the likelihood that suture strands will engage a structural member when the stands are placed closer to the opening.
[0048] Other variations in the intraluminal device may be provided. For example, at least one magnet may be provided on the wall of the device that is used to fasten the device to the cardiac portion of the stomach by engaging at least one magnet positioned in the abdominal cavity of the patient. Alternatively, the wall or the intraluminal device may be no larger than required to engage with the suture loops in the stomach, such as a narrow ring shape or the like. While such configuration may not provide as much stimulus of the baroreceptors in the cardiac portion of the stomach, it may provide sufficient stimulus of the receptors. Intraluminal device 10, 110, 210 may have various uses. The intraluminal device may be used as a bariatric device. The intraluminal device may be used to treat a metabolic disease. Because the intraluminal device resists upward movement to the stomach wall it may be used to treat gastric reflux disease or hiatal hernia.
[0049] In an alternative embodiment illustrated in FIGS 12-15, the endoscope and deployment device are combined in a combination endoscope and deployment device 324. As best illustrated in FIG. 13, combination endoscope and deployment device 324 includes the intraluminal device 10 positioned at an exterior surface of shaft 325 of the endoscope. A distal end portion 326 of endoscope shaft 325 includes a steerable portion 326 that can be retroflexed to visualize intraluminal device 10 during fastening to the cardiac portion of the stomach. Intraluminal device wall 12 is a self-expandable wall that is compressed to endoscope shaft 325. A compression device 238 keeps self-expandable wall 12 compressed to endoscope shaft 325. Compression device 238 may be a sleeve over the intraluminal device, filament wrapped over intraluminal device wall 12, or the like. A deploying filament 31 extends from compression device 328 through the esophagus to external the patient where it can be manipulated by the surgeon or surgical robot. The deploying filament is adapted to release compression device 328 to allow intraluminal device 10 to self-expand in the patient’s stomach. For example, if compression device 328 is a sleeve, it may be made with a series of openings so that a proximal force from the deploying filament will distort the sleeve to have an increase diameter to allow it to be slid off the intraluminal device. If compression device 328 is a filament wrapped over intraluminal device 10, the deploying filament may be an extension of the wrapped filament so that a proximal force from the deploying filament will remove the wrapped filament to allow the intraluminal device wall to self-expand.
[0050] Combination endoscope and deployment device 324 includes at least one filament guide
336 positioned on endoscope shaft 333 positioned proximal to intraluminal device 10 and adapted to guide movement of deploying filament 31. Filament guide 336 may also guide movement of retaining filaments 30. As best illustrated in FIG. 14, filament guide 336 includes a circular band 337 that can grip shaft 325 to stay in a stationary position. Filament guide 336 includes one or more guide channels 338 integral with band 337. Each guide channel 338 is for guiding movement of a retaining or a deploying filament 30, 31. In the illustrated embodiment, a plurality of filament guides 336 are spaced along shaft 325. [0051] While combination endoscope and deployment device 324 may be supplied compete in the configuration illustrated in FIG. 13, for example as a single-use device, a kit 330 may be provide to convert a conventional endoscope to a combination endoscope and deployment device. Kit 330 includes a holder 332 having an inner diameter that is larger than the outer diameter of the shaft of said endoscope. For example, when used with a conventional endoscope having an outer diameter of from 0.9 to 1.0 cm, holder 332 may have an inner diameter of 1.2 cm. Intraluminal device 10 is compress on holder 332 by a compression device 328 made up of a sleeve or a wrapped filament over intraluminal device 10 and adapted to keep device wall 12 compressed to the holder with deploying filament 32. Kit 330 may further include at least one filament guide 336 positioned on the holder and adapted to guide movement of the deploying filament 31. Kit 330 may further includes one or more retention filaments 30 adapted to extend from the intraluminal device to external the patient, with the filament guide adapted to guide movement of the retention filaments.
[0052] A method 339 of converting an endoscope to a combination endoscope and intraluminal device is illustrated in FIG. 15. Method 339 begins at 340 by positioning kit 330 over the shaft 325 of the endoscope with filament guides 336 proximal intraluminal device 10 and compression device 328. A first filament guide is moved to the endoscope shaft at 342 by sliding the guide off of the holder and contracting to the endoscope shaft 325. The holder is then slid distally along the endoscope at 342. If another filament guide remains on the holder (344), steps 342 and 343 are repeated. If not, the intraluminal device and compression device are moved from the holder to the endoscope shaft at 345 by sliding both off the holder where they will compress further to grip the shaft. The holder is then slid off the endoscope shaft at 346 to complete the method.
[0053] The filament guides and compression device may be removed from the endoscope shaft after the intraluminal device is affixed to the patient by reversing method 339. Alternatively, holder 332 could be retained to the endoscope’s shaft during use so that it is available for use to remove kit 330 after the intraluminal device is deployed. This may be accomplished by having friction members, such as wide bands, extending from one or both end of holder 332 to grip the shaft, other variations will be apparent to the skilled artisan.
[0054] Illustrated in FIG. 16 is a surgical robotic system 400 that is useful in carrying out the intention. Robotic system 400 has an esophageal robotic portion end-of-arm tool 404 that both deploys the intraluminal device in the stomach and visualizes the intraluminal device while it is being fastened. Robotic system 400 further has an abdominal robotic portion 406 that carries out fastening of the intraluminal device to the cardiac portion of the stomach from the abdominal cavity. A robotic control 402 adjusts the relative position between tools 404 and 406 to ensure that the intraluminal device is properly engaged by the fasteners and that the anatomy of the patient is not compromised by the deployment process.
[0055] Changes and modifications in the specifically described embodiments can be carried out without departing from the principles of the present invention which is intended to be limited only by the scope of the appended claims, as interpreted according to the principles of patent law including the doctrine of equivalents.

Claims

CLAIMS The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. An system that is adapted to deploy an intraluminal device to the cardiac region of the stomach, the system comprising: an intraluminal device comprising a wall defining a surface and an open portion of said surface that is adapted to be aligned with the gastroesophageal (GE) junction, said surface and the cardiac portion of the stomach being conformable with each other; an endoscopic deployment device that is adapted to deploying the intraluminal device trans-orally to the stomach; an endoscope that is adapted to visualize the intraluminal device in the stomach while the intraluminal device is being fastened to the cardiac portion of the stomach; and a laparoscopic instrument that is adapted to fasten the intraluminal device to the cardiac portion of the stomach from within the abdominal cavity, said laparoscopic instrument adapted to respond to said endoscope in order to guide location between said laparoscopic instrument and said intraluminal device while said laparoscopic instrument is fastening the intraluminal device.
2. The system as claimed in claim 1 wherein said system comprising a surgical robot and wherein said endoscopic deployment device and said endoscope define an esophageal robotic portion and said laparoscopic instrument defines an abdominal robotic portion and said surgical robot having a robot control controlling said esophageal robotic portion and said abdominal robotic portion.
3. The system as claimed in claim 1 wherein said deployment device comprises said endoscope with said intraluminal device positioned at an exterior surface of said endoscope.
4. The system as claimed in claim 3 wherein said endoscope shaft having a distal end portion that is adapted to be retroflexed and wherein said intraluminal device is positioned proximal of said distal end portion.
5. The system as claimed in claim 3 wherein said intraluminal device comprises a selfexpandable wall and wherein said self-expandable wall is compressed to said endoscope shaft.
6. The system as claimed in claim 5 including a compression device comprising at least one chosen from a sleeve and a wrapped filament over said intraluminal device to maintain said wall compressed to said endoscope.
7. The system as claimed in claim 6 including a deploying filament adapted to extend external the patient, said deploying filament adapted to release said compression device to allow said intraluminal device to self-expand in the patient’s stomach.
8. The system as claimed in claim 7 including at least one filament guide positioned on said endoscope shaft proximal said intraluminal device and adapted to guide movement of said deploying filament.
9. The system as claimed in claim 8 wherein said at least one filament guide comprises a plurality of said filament guides spaced along said endoscope shaft.
10. The system as claimed in claim 8 including at least one retaining filament adapted to extend from said intraluminal device to external the patient and wherein said at least one filament guide is adapted to guide movement of said at least one retaining filament.
11. The system as claimed in claim 7 wherein said deploying filament is adapted to extend external the patient through a working channel of said endoscope.
12. The system as claimed in claim 1 wherein said deployment device is adapted to align the intraluminal device in the stomach by positioning the deployment device within the open portion of the wall in order to generally align the open portion with the GE junction.
13. The system as claimed in claim 1 including a retaining device adapted to retain the intraluminal device during fastening, the retaining device comprising at least one retention filament connected with the wall and the retention filament passing through the esophagus.
14. The system as claimed in claim 1 wherein said wall has a mean radius measured from said open portion and wherein said laparoscopic instrument that is adapted to fasten the intraluminal device within a half of the radius closest to said open portion.
15. The system as claimed in claim 14 wherein said laparoscopic instrument is adapted to fasten the intraluminal device within a third of the radius closest to said open portion.
16. The system as claimed in claim 14 wherein said laparoscopic instrument is adapted to fasten the intraluminal device within a quarter of the radius closest to said open portion.
17. The system as claimed in claim 1 wherein said laparoscopic instrument is adapted to fasten the intraluminal device comprising suturing with suture strands and reinforce the suture strands at the abdominal side of each suture strand.
18. The system as claimed in claim 17 wherein said laparoscopic instrument is adapted to reinforce the suture strands comprises providing radial restraint to the suture strands.
19. The system as claimed in claim 18 wherein said providing radial restraint comprises engaging adjacent suture strands with each other.
20. The system as claimed in claim 17 wherein said reinforcing comprises producing scar material in the stomach tissue contacted by the suture strand.
21. The system as claimed in claim 20 wherein said producing scar material comprises positioning a biologically absorbable material between the suture strand and the stomach tissue.
22. The system as claimed in claim 21 wherein said suture stands are made from a nonabsorbable material.
23. The system as claimed in claim 21 wherein said biologically absorbable material comprises multiple layers, each having a different rate of absorption.
24. The system as claimed in claim 23 wherein a layer with a highest rate of absorption is positioned against the stomach wall.
25. The system as claimed in claim 23 wherein said biologically absorbable material including a structural component that resists warping.
26. The system as claimed in claim 23 wherein the one of said layers furthest from the stomach tissue having an outer surface that is adapted to resist adhering to another surface.
27. The system as claimed in claim 17 adapted to explant the intraluminal device by severing the suture strands in the stomach and pulling the knots of the severed suture strands through the stomach wall into the stomach.
28. The system as claimed in claim 1 wherein said intraluminal device has a plurality of structural members and has a higher density of said structural members proximal said open portion than distal said open portion.
29. The system as claimed in claim 1 including a controller that is adapted to adjust stress applied to the cardiac portion of the stomach with said intraluminal device.
30. The system as claimed in claim 29 wherein said controller is adapted to adjust stress comprises varying an amount of surface contact between the device wall and the stomach wall.
31. The system as claimed in claim 29 wherein said controller is adapted to adjust stress applied to the cardiac portion of the stomach with said intraluminal device with at least one bladder connected with an external port.
32. The system as claimed in claim 29 wherein said wall includes an involute collar around said open portion.
33. The system as claimed in claim 21 wherein said laparoscopic instrument is adapted to fasten the intraluminal device to the cardiac portion of the stomach from within the abdominal cavity by looping a suture strand around a structural member of the intraluminal device.
34. The system as claimed in claim 1 wherein said intraluminal device comprises one chosen from a bariatric device, a metabolic disease treatment device, a gastric reflux treatment device and a hiatal hernia treatment device.
35. A kit that is adapted for use with an endoscope having a shaft to convert said endoscope into a combination endoscope and intraluminal device release device, said kit comprising: a holder having an inner diameter that is larger than an outer diameter of the shaft of said endoscope; an intraluminal device comprising a self-expandable wall positioned on said holder; a compression device comprising one chosen from a sleeve and a wrapped filament over said intraluminal device and adapted to keep said wall compressed to said holder; and a deploying filament adapted to extend external the patient, said deploying filament adapted to release said compression device to allow said intraluminal device to self-expand.
36. The kit as claimed in claim 12 including at least one filament guide positioned on said holder and adapted to guide movement of said deploying filament.
37. The kit as claimed in claim 13 including a plurality of said filament guides positioned on said holder.
38. The kit as claimed in claim 13 wherein said holder is adapted to receive said plurality of filament guides and said compression device after use of the combination endoscope and intraluminal device.
39. A method of converting an endoscope having a shaft to a combination endoscope and intraluminal device deploying device using the kit as claimed in claim 12, said method comprising: positioning the holder over the endoscope shaft; and positioning said intraluminal device and said compression device to said shaft by moving said intraluminal device and compression device from the holder to the endoscope shaft.
40. The method as claimed in claim 39 wherein said endoscope comprises a distal end portion that is adapted to be retroflexed and including positioning said intraluminal device and said compression device proximal of said distal end portion.
41. The method as claimed in claim 39 including at least one filament guide on said holder proximal to said intraluminal device and said compression device and further including positioning said at least one filament guide on the endoscope shaft by moving said at least one filament guide from the holder to the endoscope shaft before positioning said intraluminal device and said compression device to said shaft.
42. The method as claimed in claim 41 including sliding said holder distally after moving said at least one filament guide from the holder to the endoscope shaft and before moving said intraluminal device and compression device from the holder to the endoscope shaft.
43. The method as claimed in claim 42 wherein said at least one filament guide comprises a plurality of said filament guides and wherein said positioning plurality of said filament guides includes sliding said holder distally after moving each of said filament guides from the holder to the shaft.
44. The method as claimed in claim 41 wherein said at least one filament guide comprises a plurality of said filament guides and wherein said positioning plurality of said filament guides includes sliding said holder distally after moving each of said filament guides from the holder to the shaft.
PCT/IB2023/051970 2022-03-04 2023-03-02 Method of deploying an intraluminal device and intraluminal system Ceased WO2023166472A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP23763075.1A EP4486261A4 (en) 2022-03-04 2023-03-02 Method for introducing an intraluminal device and intraluminal system
AU2023229218A AU2023229218A1 (en) 2022-03-04 2023-03-02 Method of deploying an intraluminal device and intraluminal system
CA3255550A CA3255550A1 (en) 2022-03-04 2023-03-02 Method of deploying an intraluminal device and intraluminal system
KR1020247033214A KR20240161142A (en) 2022-03-04 2023-03-02 How to deploy in-house devices and in-house systems

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202263316714P 2022-03-04 2022-03-04
US63/316,714 2022-03-04
US202263385700P 2022-12-01 2022-12-01
US63/385,700 2022-12-01
US202363486544P 2023-02-23 2023-02-23
US63/486,544 2023-02-23

Publications (2)

Publication Number Publication Date
WO2023166472A2 true WO2023166472A2 (en) 2023-09-07
WO2023166472A3 WO2023166472A3 (en) 2023-10-12

Family

ID=87851657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2023/051970 Ceased WO2023166472A2 (en) 2022-03-04 2023-03-02 Method of deploying an intraluminal device and intraluminal system

Country Status (6)

Country Link
US (6) US12599493B2 (en)
EP (1) EP4486261A4 (en)
KR (1) KR20240161142A (en)
AU (1) AU2023229218A1 (en)
CA (1) CA3255550A1 (en)
WO (1) WO2023166472A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260019610A (en) * 2023-06-05 2026-02-10 비에프케이더블유, 엘엘씨 Method for fixing a device within a tube, a fixing system within a tube, and a fastener within a tube
WO2025141332A1 (en) * 2023-12-28 2025-07-03 Bfkw, Llc Intraluminal device and method of applying stress to baroreceptors in the gastro-intestinal tract

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096673A1 (en) 2003-10-10 2005-05-05 Stack Richard S. Devices and methods for retaining a gastro-esophageal implant
US7846174B2 (en) 2004-10-15 2010-12-07 Bfkw, Llc Bariatric device and method
US20160151233A1 (en) 2013-08-27 2016-06-02 Bfkw, Llc Method and device for treating metabolic disease

Family Cites Families (195)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4403604A (en) 1982-05-13 1983-09-13 Wilkinson Lawrence H Gastric pouch
US4607618A (en) 1983-02-23 1986-08-26 Angelchik Jean P Method for treatment of morbid obesity
US5084058A (en) * 1990-04-25 1992-01-28 Mitek Surgical Products, Inc. Suture rundown tool and cutter system
US5234454A (en) 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5662713A (en) 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
AU678350B2 (en) 1992-05-08 1997-05-29 Schneider (Usa) Inc. Esophageal stent and delivery tool
RU2045233C1 (en) 1992-06-22 1995-10-10 Тарабарин Сергей Андреевич Method for surgically treating pathologic obesity
US5496280A (en) 1992-07-02 1996-03-05 Applied Medical Resources Corporation Trocar valve assembly
US5578044A (en) 1992-09-04 1996-11-26 Laurus Medical Corporation Endoscopic suture system
US5306300A (en) 1992-09-22 1994-04-26 Berry H Lee Tubular digestive screen
EP0664689A4 (en) 1992-10-13 1997-02-26 Boston Scient Corp Stents for body lumens exhibiting peristaltic.
US5507755A (en) 1993-08-03 1996-04-16 Origin Medsystems, Inc. Apparatus and method for closing puncture wounds
RU94026119A (en) 1994-07-14 1996-08-20 Нижегородский государственный медицинский институт Method for surgical treatment of morbid obesity cases
US20070010875A1 (en) 1997-06-30 2007-01-11 Trout Hugh H Method and apparatus to attach an unsupported surgical component
US5820584A (en) 1997-08-28 1998-10-13 Crabb; Jerry A. Duodenal insert and method of use
US6086600A (en) 1997-11-03 2000-07-11 Symbiosis Corporation Flexible endoscopic surgical instrument for invagination and fundoplication
US6254642B1 (en) 1997-12-09 2001-07-03 Thomas V. Taylor Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
US6113609A (en) 1998-05-26 2000-09-05 Scimed Life Systems, Inc. Implantable tissue fastener and system for treating gastroesophageal reflux disease
US6591838B2 (en) 1998-07-06 2003-07-15 Scimed Life Systems, Inc. Implant system and method for bulking tissue
US6264700B1 (en) 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve
US6746489B2 (en) 1998-08-31 2004-06-08 Wilson-Cook Medical Incorporated Prosthesis having a sleeve valve
WO2000016701A1 (en) 1998-09-18 2000-03-30 United States Surgical Corporation Endovascular fastener applicator
US6280415B1 (en) 1999-03-10 2001-08-28 W. Dudley Johnson Tissue traction device
US6398802B1 (en) 1999-06-21 2002-06-04 Scimed Life Systems, Inc. Low profile delivery system for stent and graft deployment
US7744613B2 (en) 1999-06-25 2010-06-29 Usgi Medical, Inc. Apparatus and methods for forming and securing gastrointestinal tissue folds
US20050192629A1 (en) 1999-06-25 2005-09-01 Usgi Medical Inc. Methods and apparatus for creating and regulating a gastric stoma
US20040122456A1 (en) 2002-12-11 2004-06-24 Saadat Vahid C. Methods and apparatus for gastric reduction
CN1250168C (en) 1999-08-12 2006-04-12 波滕西亚医疗公司 A device that creates a stoma in a patient's stomach or esophagus
US6387104B1 (en) 1999-11-12 2002-05-14 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6592596B1 (en) 2000-05-10 2003-07-15 Scimed Life Systems, Inc. Devices and related methods for securing a tissue fold
US6540789B1 (en) 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
US6432040B1 (en) 2000-09-14 2002-08-13 Nizam N. Meah Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method
US6736828B1 (en) 2000-09-29 2004-05-18 Scimed Life Systems, Inc. Method for performing endoluminal fundoplication and apparatus for use in the method
US7033373B2 (en) 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US6468298B1 (en) 2000-12-28 2002-10-22 Advanced Cardiovascular Systems, Inc. Gripping delivery system for self-expanding stents and method of using the same
US6572627B2 (en) 2001-01-08 2003-06-03 Shlomo Gabbay System to inhibit and/or control expansion of anatomical features
JP4202138B2 (en) 2001-01-31 2008-12-24 レックス メディカル インコーポレイテッド Apparatus and method for stapling and ablating gastroesophageal tissue
US7066945B2 (en) 2001-05-17 2006-06-27 Wilson-Cook Medical Inc. Intragastric device for treating obesity
US6916332B2 (en) 2001-05-23 2005-07-12 Scimed Life Systems, Inc. Endoluminal fundoplication device and related method for installing tissue fastener
US7087088B2 (en) 2001-05-24 2006-08-08 Torax Medical, Inc. Methods and apparatus for regulating the flow of matter through body tubing
US7083629B2 (en) 2001-05-30 2006-08-01 Satiety, Inc. Overtube apparatus for insertion into a body
US6558400B2 (en) 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US6675809B2 (en) 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US20040117031A1 (en) 2001-08-27 2004-06-17 Stack Richard S. Satiation devices and methods
US6845776B2 (en) 2001-08-27 2005-01-25 Richard S. Stack Satiation devices and methods
CN101810521B (en) * 2001-08-27 2015-05-13 辛尼科有限责任公司 Satiation devices and methods
US7097665B2 (en) 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
US20080015633A1 (en) 2001-09-06 2008-01-17 Ryan Abbott Systems and Methods for Treating Septal Defects
US6740121B2 (en) 2001-11-09 2004-05-25 Boston Scientific Corporation Intragastric stent for duodenum bypass
US6755869B2 (en) 2001-11-09 2004-06-29 Boston Scientific Corporation Intragastric prosthesis for the treatment of morbid obesity
US7146984B2 (en) 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US6960233B1 (en) 2002-12-10 2005-11-01 Torax Medical, Inc. Methods and apparatus for improving the function of biological passages
US7695427B2 (en) 2002-04-26 2010-04-13 Torax Medical, Inc. Methods and apparatus for treating body tissue sphincters and the like
US7445010B2 (en) 2003-01-29 2008-11-04 Torax Medical, Inc. Use of magnetic implants to treat issue structures
US20050197715A1 (en) 2002-04-26 2005-09-08 Torax Medical, Inc. Methods and apparatus for implanting devices into non-sterile body lumens or organs
EP1503700B1 (en) 2002-05-08 2012-09-26 Abbott Laboratories Endoprosthesis having foot extensions
DE10221076A1 (en) 2002-05-11 2003-11-27 Ruesch Willy Gmbh stent
US6773440B2 (en) 2002-07-02 2004-08-10 Satiety, Inc. Method and device for use in tissue approximation and fixation
US6746460B2 (en) 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7211114B2 (en) 2002-08-26 2007-05-01 The Trustees Of Columbia University In The City Of New York Endoscopic gastric bypass
EP1531762B1 (en) 2002-08-29 2010-04-14 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the internal circumference of an anatomic orifice or lumen
US7083630B2 (en) 2002-08-29 2006-08-01 Scimed Life Systems, Inc. Devices and methods for fastening tissue layers
US7033384B2 (en) 2002-08-30 2006-04-25 Satiety, Inc. Stented anchoring of gastric space-occupying devices
US6981978B2 (en) 2002-08-30 2006-01-03 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US20090149871A9 (en) 2002-11-01 2009-06-11 Jonathan Kagan Devices and methods for treating morbid obesity
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7794447B2 (en) 2002-11-01 2010-09-14 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US8070743B2 (en) 2002-11-01 2011-12-06 Valentx, Inc. Devices and methods for attaching an endolumenal gastrointestinal implant
US9060844B2 (en) * 2002-11-01 2015-06-23 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7837669B2 (en) 2002-11-01 2010-11-23 Valentx, Inc. Devices and methods for endolumenal gastrointestinal bypass
US6656194B1 (en) 2002-11-05 2003-12-02 Satiety, Inc. Magnetic anchoring devices
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
JP4391765B2 (en) 2002-12-02 2009-12-24 オリンパス株式会社 Endoscopic mucosal resection tool
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US7491234B2 (en) 2002-12-03 2009-02-17 Boston Scientific Scimed, Inc. Medical devices for delivery of therapeutic agents
US8627992B2 (en) 2002-12-16 2014-01-14 Edrich Health Technologies, Inc. Endovascular stapler
US20040143342A1 (en) 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US7444183B2 (en) 2003-02-03 2008-10-28 Enteromedics, Inc. Intraluminal electrode apparatus and method
US20040220682A1 (en) 2003-03-28 2004-11-04 Gi Dynamics, Inc. Anti-obesity devices
FR2853829B1 (en) 2003-04-16 2005-07-08 Cie Euro Etude Rech Paroscopie INTRODUCTION KIT FOR AN INTRA-GASTRIC IMPLANT, CASE FOR INTRODUCING SUCH AN IMPLANT AND CORRESPONDING MANUFACTURING METHOD
US7041127B2 (en) 2003-05-28 2006-05-09 Ledergerber Walter J Textured and drug eluting coronary artery stent
US6994095B2 (en) 2003-07-28 2006-02-07 Medventure Associates Iv Pyloric valve corking device and method
US7771384B2 (en) 2003-08-20 2010-08-10 Biagio Ravo Trocar with integral irrigation and suction tube
US7758625B2 (en) 2003-09-12 2010-07-20 Abbott Vascular Solutions Inc. Delivery system for medical devices
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
US7097650B2 (en) 2003-10-14 2006-08-29 Satiety, Inc. System for tissue approximation and fixation
US7758493B2 (en) * 2003-10-23 2010-07-20 Proxy Biomedical Limited Gastric constriction device
US7232461B2 (en) 2003-10-29 2007-06-19 Cordis Neurovascular, Inc. Neck covering device for an aneurysm
EP1708655A1 (en) 2003-12-09 2006-10-11 GI Dynamics, Inc. Apparatus to be anchored within the gastrointestinal tract and anchoring method
US20050131515A1 (en) 2003-12-16 2005-06-16 Cully Edward H. Removable stent-graft
WO2005058210A1 (en) 2003-12-19 2005-06-30 Patrick Leahy An anti-reflux system
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7449024B2 (en) 2003-12-23 2008-11-11 Abbott Laboratories Suturing device with split arm and method of suturing tissue
US8828025B2 (en) 2004-02-13 2014-09-09 Ethicon Endo-Surgery, Inc. Methods and devices for reducing hollow organ volume
US9028511B2 (en) 2004-03-09 2015-05-12 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8252009B2 (en) 2004-03-09 2012-08-28 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
ES2552252T3 (en) 2004-03-23 2015-11-26 Boston Scientific Limited Live View System
US20060264699A1 (en) 2004-10-27 2006-11-23 Michael Gertner Extragastric minimally invasive methods and devices to treat obesity
US7255675B2 (en) 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
WO2006049725A2 (en) 2004-03-23 2006-05-11 Minimus Surgical Systems Surgical systems and devices to enhance gastric restriction therapies
CA2561193A1 (en) 2004-03-26 2005-10-20 Satiety, Inc. Systems and methods for treating obesity
US20050245788A1 (en) 2004-04-28 2005-11-03 Medtronic, Inc. Esophageal delivery system and method with position indexing
US20050245957A1 (en) 2004-04-30 2005-11-03 Medtronic, Inc. Biasing stretch receptors in stomach wall to treat obesity
US7736374B2 (en) 2004-05-07 2010-06-15 Usgi Medical, Inc. Tissue manipulation and securement system
US20050251176A1 (en) 2004-05-07 2005-11-10 Usgi Medical Inc. System for treating gastroesophageal reflux disease
US20060020277A1 (en) 2004-07-20 2006-01-26 Gostout Christopher J Gastric reshaping devices and methods
US8452407B2 (en) 2004-08-16 2013-05-28 Boston Scientific Neuromodulation Corporation Methods for treating gastrointestinal disorders
EP1799145B1 (en) 2004-09-17 2016-12-21 GI Dynamics, Inc. Gastrointestinal anchor
US20060155375A1 (en) 2004-09-27 2006-07-13 Jonathan Kagan Devices and methods for attachment of a gastrointestinal sleeve
JP4610286B2 (en) 2004-10-05 2011-01-12 株式会社シーエックスカーゴ Sorting equipment and sorting method
KR101696006B1 (en) * 2004-10-15 2017-01-13 비에프케이더블유, 엘엘씨 Bariatric device and method for recipient with altered anatomy
RU2386455C2 (en) 2004-10-15 2010-04-20 БиЭфКейДаблЮ, ЭлЭлСи Device and method for obesity treatment
US7771382B2 (en) 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
EP1846080A4 (en) 2005-01-19 2010-05-19 Sentinel Group Llc Medical agent delivery system and method
US20060240096A1 (en) * 2005-04-22 2006-10-26 Kugler Chad J Devices and methods for treating the gastrointestinal system
US7310557B2 (en) 2005-04-29 2007-12-18 Maschino Steven E Identification of electrodes for nerve stimulation in the treatment of eating disorders
US20060253131A1 (en) 2005-05-03 2006-11-09 Endogastric Solutions, Inc. Tissue fixation assemblies providing single stroke deployment
US7674271B2 (en) 2005-05-04 2010-03-09 InTailor Surgical, Inc. Endoluminal gastric ring and method
ES2498216T3 (en) 2005-05-11 2014-09-24 Board Of Regents, The University Of Texas System Device to treat obesity
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US20070088428A1 (en) 2005-09-15 2007-04-19 Cappella, Inc. Intraluminal device with asymmetric cap portion
WO2007059414A2 (en) * 2005-11-10 2007-05-24 Sentinel Group, Llc Intragastric and transgastric device and method of visualization and therapeutic intervention
US20080215076A1 (en) * 2005-11-14 2008-09-04 Sentinel Group, Llc Gastro-intestinal therapeutic device and method
CN100362971C (en) 2005-11-16 2008-01-23 程英升 Cardia stent
US20070123994A1 (en) 2005-11-29 2007-05-31 Ethicon Endo-Surgery, Inc. Internally Placed Gastric Restriction Device
US20070179590A1 (en) 2005-12-29 2007-08-02 Wenfeng Lu Hybrid intraluminal device with varying expansion force
WO2007084278A2 (en) 2006-01-06 2007-07-26 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix based gastroesophageal junction reinforcement device
US7442589B2 (en) 2006-01-17 2008-10-28 Honeywell International Inc. System and method for uniform multi-plane silicon oxide layer formation for optical applications
ES2672997T3 (en) 2006-02-03 2018-06-19 Baronova, Inc. Devices for gastrointestinal stimulation
US20070198035A1 (en) 2006-02-17 2007-08-23 Threlkeld Judson E Method and surgical instrument operable for percutaneous ligation of a vein or vessel
US20070233221A1 (en) 2006-03-31 2007-10-04 The Board Of Regents, The University Of Texas System Esophageal dilation and stent delivery system and method of use
US8690831B2 (en) 2008-04-25 2014-04-08 Ethicon Endo-Surgery, Inc. Gas jet fluid removal in a trocar
JP2009536083A (en) 2006-05-03 2009-10-08 インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション Method and apparatus for reconstructing the esophagus and other body lumens
IL176889A0 (en) 2006-07-16 2006-10-31 Medigus Ltd Devices and methods for treating morbid obesity
EP2073725B1 (en) 2006-08-01 2015-05-06 Cook Medical Technologies LLC Improved system and method for endoscopic treatment of tissue
US8142513B2 (en) 2006-08-23 2012-03-27 Svip 2 Llc Devices and methods for altering eating behavior
US20080065136A1 (en) 2006-08-30 2008-03-13 Andrew Young Distender device and method for treatment of obesity and metabolic and other diseases
CN101795627A (en) 2006-10-04 2010-08-04 伊西康内外科公司 Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery
US8372087B2 (en) 2007-02-14 2013-02-12 Bfkw, Llc Medical device fixation tool and method of fixation of a medical device
CN101626806B (en) 2007-02-14 2013-03-20 Bfkw有限公司 bariatric device
US8529431B2 (en) 2007-02-14 2013-09-10 Bfkw, Llc Bariatric device and method
EP2114302B1 (en) * 2007-02-14 2018-12-26 Bfkw, Llc Mucosal capture fixation of medical device
WO2008101078A2 (en) 2007-02-14 2008-08-21 Bfkw, Llc Medical device fixation tool and method of fixation of a medical device
US20080262514A1 (en) 2007-04-20 2008-10-23 Christoph Gasche Systems and methods for endoscopic treatment of diverticula
WO2009048398A1 (en) 2007-10-11 2009-04-16 Milux Holding Sa Method for controlling flow in a stomach
WO2009064408A1 (en) 2007-11-12 2009-05-22 Dilorenzo Daniel J Method and apparatus for programming of autonomic neuromodulation for the treatment of obesity
EP2240215B1 (en) 2008-01-17 2014-01-08 Boston Scientific Scimed, Inc. Stent with anti-migration feature
KR100988816B1 (en) 2008-01-29 2010-10-20 신경민 Double Encapsulated Stent for Bile Ducts
DE202008007774U1 (en) 2008-06-11 2008-08-14 Ovesco Endoscopy Gmbh endoscope cap
US20100010298A1 (en) 2008-07-14 2010-01-14 Ethicon Endo-Surgery, Inc. Endoscopic translumenal flexible overtube
US20110264234A1 (en) 2008-08-21 2011-10-27 Sentinel Group, Llc Gastro-esophageal reflux disease reduction device and method
EP2414026A2 (en) 2009-03-31 2012-02-08 Onciomed, Inc. Method and apparatus for treating obesity and controlling weight gain using self-expanding intragastric devices
CA2756991A1 (en) 2009-04-03 2010-10-07 Metamodix, Inc. Modular gastrointestinal prostheses
DE202010017584U1 (en) 2009-05-08 2012-02-29 Université Libre de Bruxelles Gastrointestinal device
US20100305590A1 (en) 2009-05-29 2010-12-02 Gi Dynamics, Inc. Transpyloric Anchoring
US20110004146A1 (en) 2009-07-01 2011-01-06 E2 Llc Systems and Methods for Treating of Obesity and Type 2 Diabetes
WO2011006098A2 (en) 2009-07-10 2011-01-13 Metamodix, Inc. External anchoring configurations for modular gastrointestinal prostheses
CA2781524C (en) 2009-10-26 2018-06-19 Innovelle, Llc Bariatric device and method for weight loss
DE102009051408A1 (en) 2009-10-30 2011-05-05 Ovesco Endoscopy Ag Medical instrument for setting tissue clips
US20120232361A1 (en) * 2009-11-20 2012-09-13 Allergan, Inc. Bariatric instrument or accessory with sensors
US8475525B2 (en) 2010-01-22 2013-07-02 4Tech Inc. Tricuspid valve repair using tension
EP2531137A1 (en) 2010-02-02 2012-12-12 Bfkw, Llc Bariatric device and method for recipient with altered anatomy
US8447404B2 (en) 2010-03-05 2013-05-21 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
WO2011116025A1 (en) 2010-03-15 2011-09-22 Innovelle, Llc Bariatric device and method for weight loss
US8778011B2 (en) 2010-09-30 2014-07-15 Cook Medical Technologies Llc Soft crowns
US20130296913A1 (en) * 2010-10-01 2013-11-07 Bfkw, Llc Intraluminal device and method
US20120095497A1 (en) 2010-10-19 2012-04-19 Allergan, Inc. Non-inflatable gastric implants and systems
AU2011323533B2 (en) * 2010-11-01 2015-03-26 The Cleveland Clinic Foundation Preformed gastric band and method of use
US10111663B2 (en) 2011-02-18 2018-10-30 Ancora Heart, Inc. Implant retrieval device
WO2012136249A1 (en) 2011-04-05 2012-10-11 Ethicon Endo-Surgery, Inc. An endoluminal lining system and a method for endoluminally lining a hollow organ
CN103619281B (en) 2011-05-20 2016-02-24 Bfkw有限公司 Intraluminal devices with enhanced anti-migration
US9549833B2 (en) 2011-10-11 2017-01-24 Cook Medical Technologies Llc Stent delivery, repositioning, and removal system
WO2013090190A1 (en) 2011-12-14 2013-06-20 Bfkw, Llc Luminal overtube and method of accessing a portion of the lumen
US9545326B2 (en) * 2012-03-06 2017-01-17 Bfkw, Llc Intraluminal device delivery technique
US20130310326A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
US9039649B2 (en) 2012-05-31 2015-05-26 Valentx, Inc. Devices and methods for gastrointestinal bypass
US20140158747A1 (en) 2012-12-06 2014-06-12 Ethicon Endo-Surgery, Inc. Surgical stapler with varying staple widths along different circumferences
WO2014141239A1 (en) 2013-03-14 2014-09-18 4Tech Inc. Stent with tether interface
US9254204B2 (en) 2013-03-15 2016-02-09 Cook Medical Technologies Llc Stents having barbs protected during delivery
US20140277341A1 (en) 2013-03-15 2014-09-18 Cook Medical Technologies Llc Wireless medical device release mechanism
US9456917B2 (en) * 2013-08-28 2016-10-04 Ethicon Endo-Surgery, Inc. Endoscopic transoral duodenal sleeve applier
US20150182239A1 (en) * 2014-01-02 2015-07-02 Bfkw, Llc Endoscopic fixation of a medical device using mucosal capture
WO2018083632A1 (en) 2016-11-03 2018-05-11 Bfkw, Llc Intraluminal device and method with fixation technique
US11013629B2 (en) * 2014-12-29 2021-05-25 Bfkw, Llc Fixation of intraluminal device
US11020213B2 (en) * 2014-12-29 2021-06-01 Bfkw, Llc Fixation of intraluminal device
CA2972582A1 (en) 2014-12-29 2016-07-07 Bfkw, Llc Fixation of intraluminal device
US11123204B2 (en) 2015-02-06 2021-09-21 Boston Scientific Scimed, Inc. Anti-migration stent
US10569071B2 (en) * 2015-08-31 2020-02-25 Ethicon Llc Medicant eluting adjuncts and methods of using medicant eluting adjuncts
WO2018073752A1 (en) 2016-10-17 2018-04-26 Bfkw, Llc Intraluminal device and fixation technique
WO2019099813A1 (en) * 2017-11-17 2019-05-23 Musara Mubayiwa Cornelious Multilayered biologic mesh and methods of use thereof
WO2019191652A1 (en) 2018-03-30 2019-10-03 Metamodix, Inc. Systems and methods for anchoring and restraining gastrointestinal prostheses
CN108938163B (en) 2018-04-12 2023-12-26 杭州糖吉医疗科技有限公司 Gastric diverter and method of releasing it
EP3937846B1 (en) 2019-03-11 2024-07-10 Bfkw, Llc Intraluminal device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096673A1 (en) 2003-10-10 2005-05-05 Stack Richard S. Devices and methods for retaining a gastro-esophageal implant
US7846174B2 (en) 2004-10-15 2010-12-07 Bfkw, Llc Bariatric device and method
US20160151233A1 (en) 2013-08-27 2016-06-02 Bfkw, Llc Method and device for treating metabolic disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP4486261A4

Also Published As

Publication number Publication date
US20250134686A1 (en) 2025-05-01
US20250127641A1 (en) 2025-04-24
EP4486261A2 (en) 2025-01-08
US20250127643A1 (en) 2025-04-24
US20250127642A1 (en) 2025-04-24
US20260115029A1 (en) 2026-04-30
WO2023166472A3 (en) 2023-10-12
CA3255550A1 (en) 2023-09-07
AU2023229218A1 (en) 2024-09-19
KR20240161142A (en) 2024-11-12
US20230277350A1 (en) 2023-09-07
EP4486261A4 (en) 2025-08-20
US12599493B2 (en) 2026-04-14

Similar Documents

Publication Publication Date Title
US20250127641A1 (en) System adapted to deploy an intraluminal device
US20250160818A1 (en) Endoscopic suture loop anchors and methods
US7892214B2 (en) Attachment system for transmural attachment at the gastroesophageal junction
US7837669B2 (en) Devices and methods for endolumenal gastrointestinal bypass
US20050070931A1 (en) Method and apparatus for creating a restriction in the stomach or other anatomical structure
CN102014807A (en) Tissue apposition method and device involving sheets with integrated tensioning system
JP6490179B2 (en) Medical devices and instruments for adjustment and cutting
US20260007532A1 (en) Method of fixation of intraluminal device, intraluminal fixation system and intraluminal fastener

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23763075

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2023229218

Country of ref document: AU

Date of ref document: 20230302

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 202417073262

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 20247033214

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020247033214

Country of ref document: KR

Ref document number: 2023763075

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2023763075

Country of ref document: EP

Effective date: 20241004

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23763075

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 202417073262

Country of ref document: IN